Takeda's HYQVIA gains FDA approval for CIDP maintenance therapy

ANGLE signs USD250,000 contract with Eisai for HER2 assay pilot study

genedrive secures initial overseas orders for Genedrive MT-RNR1 ID kit

Grindr partners with Equality Movement and MPOWER to introduce at-home HIV testing in Georgia and Ireland

Kromek collaborates on next-gen CT detector technology

Gilead Sciences initiates Phase 2 trial in Europe to evaluate lenacapavir for HIV prevention

European Commission grants authorisation to ViiV Healthcare's Apretude for prevention of HIV

Celanese to supply VitalDose drug delivery platform for Population Council's MPT Intravaginal Ring

Gilead, Tentarix Team to Discover and Develop Novel Therapies to Address Unmet Medical Needs Across Cancer and Inflammation

Henry Schein introduces equipment repair subscription - Henry Schein Thrive Service Plus

Seres Therapeutics provides business updates and reports Q2 2023 financial results

Gilead Presents New Biktarvy Data

Gilead Sciences Makes Largest Commitment to Health Equity for Australian and Canadian Indigenous Communities

Invivoscribe receives FDA approval for LeukoStrat CDx FLT3 Mutation Assay to aid in treatment selection for AML patients

Gilead Partners with CHAI and Penta to Improve Treatment and Adherence Rates Among Children with HIV in Low and Middle Income Countries